MMP14 empowers tumor‐initiating breast cancer cells under hypoxic nutrient‐depleted conditions

Abstract

Tumor‐initiating cells (TICs) existing in breast cancer are thought to be involved in initiation, progression, and relapse of tumors. In these processes, the epithelial‐to‐mesenchymal transition (EMT) and proteases are crucial factors that also dependent on the tumor milieu, including hypoxic nutrient‐deprived, as well as normoxic nutrient‐rich, environments. Therefore, we investigated EMT and proteases in TICs and their response to different environments by means of a newly generated immortalized TIC (iTIC) line. With the use of primary CD24+CD90+CD45− TICs from the mouse mammary tumor virus‐polyoma middle T mouse breast cancer model, iTICs were generated by single cell‐initiated sphere and subsequent 2‐dimensional monolayer culture. Our data demonstrate the possibility to generate iTICs that are highly tumorigenic in culture and in mouse mammary fat pad. Contrasting environmental conditions provide these cells with a phenotypic and molecular plasticity that has a growth‐promoting character in nutrient‐rich normoxia and a motile character in nutrient‐deprived hypoxia. Expression profiling revealed partial and dynamically changing EMT states, as well as a significantly up‐regulated proteolytic signature, including many metalloproteinases, such as matrix metalloproteinase 14 (Mmp14). Inhibitor treatment of metalloproteinases, as well as short hairpin RNA‐mediated knockdown of Mmp14 strongly impacted TIC characteristics, including tumor initiation, cell growth, migration, and invasion, especially in starved environments. We conclude that metalloproteinases empower TICs to adapt to changing environments.—Hillebrand, L. E., Wickberg, S. M., Gomez‐Auli, A., Folio, M., Maurer, J., Busch, H., Boerries, M., Reinheckel, T. MMP14 empowers tumor‐initiating breast cancer cells under hypoxic nutrient‐depleted conditions. FASEB J. 33, 4124–4140 (2019). http://www.fasebj.org

Conditional Gene Targeting Reveals Cell Type-Specific Roles of the Lysosomal Protease Cathepsin L in Mammary Tumor Progression

“…Proteolysis is a fundamental event at every single stage of tumorigenesis [1,2]. Cysteine cathepsins modulate physiological as well as pathological processes as important components of the intracellular proteolytic network [3].…”

The Expanding Role of MT1-MMP in Cancer Progression

“…Gliomas induce MT1-MMP expression and activity in microglial cells [11]. Cancer stems cells/tumor-initiating cells require MT1-MMP for growth, tumor initiation, invasion and metastasis, particularly in hypoxic, nutrient-deprived environments [12]. MT1-MMP is generally considered pro-invasive and pro-tumorigenic as (a) the expression and activity of MT1-MMP are elevated in tumor tissues and (b) high levels of MT1-MMP directly correlate with enhanced cell migration and tumor regional invasion/remote metastasis [13,14].…”

Theranostic nanoparticles enhance the response of glioblastomas to radiation

“…MMP-14 is a membrane-bound protein that plays a role in the degradation of structural proteins in the extracellular matrix and has been identified as an important target for cancer diagnostics and therapy 13, 33. In addition, MMP-14 is also regarded as a marker for GICs 13-15, which makes it a potential target for our drug. As expected, we found a significant reduction in CD15 staining (a marker for glioblastoma initiating cells) in CLIO-ICT and CLIO-ICT plus radiation treated mice, confirming that CLIO-ICT targets cells that have been previously reported as radio-resistant.…”

“…CLIO and ICT2552 are linked through an MMP-14-cleavable linker to afford the MMP-14 activatable theranostic drug, CLIO-ICT 12. Matrix metalloproteinase 14 (MMP-14) is a membrane-bound protein playing an important role in the stemness of aggressive cancers, including GBM 13-15, which makes it an appealing therapeutic target for GICs.…”